drug · antibody

imzokitug

Phase 2updated 3mo ago

by Bristol-Myers Squibb Co🔗 ChEMBL

Phase 2

community read0 votes

Antibody drug with a maximum clinical stage of Phase 2, with 1 investigational indication.

indications

NSCLCColorectal Cancer

all catalysts(0)

nothing on the calendar yet

Trials studying imzokitug

phase2A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)recruitingn=160

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 42m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug · antibody

save

imzokitug

Phase 2updated 3mo ago

by Bristol-Myers Squibb Co🔗 ChEMBL

Phase 2

community read0 votes

Antibody drug with a maximum clinical stage of Phase 2, with 1 investigational indication.

indications

NSCLCColorectal Cancer

all catalysts(0)

nothing on the calendar yet

Trials studying imzokitug

phase2A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)recruitingn=160

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 42m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

imzokitug

indications

all catalysts(0)

Trials studying imzokitug

News(0)

Report a data issue

comments(0)

imzokitug

indications

all catalysts(0)

Trials studying imzokitug

News(0)

Report a data issue

comments(0)